Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial.
暂无分享，去创建一个
P. Fasching | A. Schneeweiss | C. Denkert | S. Loibl | M. Untch | V. Nekljudova | J. Huober | K. Engels | C. Jackisch | C. Hanusch | C. Solbach | K. Rhiem | O. Stötzer | P. Wimberger | M. Thill | M. Reinisch | T. Link | Jens-Uwe Blohmer | F. Seither | S. Seiler | M. Just | J. Blohmer